Trilogy Capital’s Vanguard Morningstar Mid-Cap Growth ETF VOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$203K Sell
694
-1,214
-64% -$364K 0.01% 402
2026
Q2
$584K Buy
1,908
+1
+0.1% +$288 0.02% 253
2026
Q1
$491K Sell
1,907
-187
-9% -$51.3K 0.02% 266
2025
Q4
$585K Sell
2,094
-21
-1% -$6.01K 0.03% 234
2025
Q3
$621K Sell
2,115
-49
-2% -$14.1K 0.03% 228
2025
Q2
$616K Buy
2,164
+245
+13% +$63.2K 0.03% 212
2025
Q1
$470K Hold
1,919
– – 0.02% 227
2024
Q4
$487K Buy
1,919
+1
+0.1% +$257 0.03% 229
2024
Q3
$467K Buy
1,918
+100
+6% +$23.3K 0.02% 229
2024
Q2
$417K Buy
+1,818
New +$417K 0.02% 228
2018
Q4
– Sell
-445
Closed -$63K – 557
2018
Q3
$63K Buy
445
+98
+28% +$13.7K 0.01% 184
2018
Q2
$47K Buy
347
+139
+67% +$18.5K 0.01% 187
2018
Q1
$27K Buy
+208
New +$27.3K ﹤0.01% 206

Other funds holding VOT

Trilogy Capital's VOT Position: Q3 2026 in Review

Trilogy Capital reduced its Vanguard Morningstar Mid-Cap Growth ETF (VOT) stake by 64% in Q3 2026, selling an estimated $364K and leaving 694 shares worth $203K. The position accounts for 0.01% of the portfolio, ranked #402.

Trilogy Capital first reported a position in VOT in Q1 2018 and has held it in 13 quarters since. The position peaked at $621K in Q3 2025. 694 funds tracked by Wall St. Rank hold VOT as of Q3 2026.

  • Trilogy Capital held 694 shares of Vanguard Morningstar Mid-Cap Growth ETF worth $203K as of Q3 2026.
  • Trilogy Capital sold 1,214 Vanguard Morningstar Mid-Cap Growth ETF shares in Q3 2026, an estimated $364K.
  • Vanguard Morningstar Mid-Cap Growth ETF made up 0.01% of Trilogy Capital's portfolio in Q3 2026, its #402 holding.
  • Trilogy Capital first reported a position in Vanguard Morningstar Mid-Cap Growth ETF in Q1 2018 and has held it in 13 quarters since.
  • Trilogy Capital's Vanguard Morningstar Mid-Cap Growth ETF position peaked at $621K in Q3 2025.
  • 694 funds tracked by Wall St. Rank held Vanguard Morningstar Mid-Cap Growth ETF as of Q3 2026.

Based on Trilogy Capital's 13F filing for Q3 2026, filed 20 Oct 2026.